Marketing Authorisation (MA) is the regulatory act that allows a medicine to be marketed in a country or region.
It is granted after evaluation of quality, efficacy, and safety data. Without an MA, a medicine cannot be distributed outside of exceptional frameworks (early or compassionate access).
MA ensures that the product meets the required standards for safe use in patients.
